UiPath Inc. is rated a strong buy, with a price target near $18, following a 30% sell-off driven by AI-related sector fears. PATH's robust AI-driven automation platform, strong earnings beats, and 16% ...
GMO's aim is to provide an anatomy of a technology mania, constructed from historical and more recent experience. GMO believes that we are in a U.S. stock market and AI bubble, and that at some stage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results